Three‐Level Nanoparticle Rocket Strategy for Colorectal Cancer Therapeutics in Photothermal Therapy, Inflammation Modulation, and Cuproptosis Induction
Authors:
- 10 January 2025
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (6) , e2403939
Abstract
Disturbances in intracellular copper (Cu) homeostasis can trigger cuproptosis, a new form of cell death, which, when combined with photothermal therapy (PTT), offers a promising solution to the persistent challenges in colorectal cancer (CRC) treatment. In this study, a “three‐level nanoparticle rocket” strategy is developed by engineering Cu5.4O, a multifunctional Cu‐based nanoenzyme that is photothermal and has electron transfer properties and antioxidant efficiency. Cu5.4O effectively remodels the inflammatory environment by scavenging reactive oxygen species, thereby overcoming the traditional limitations of PTT. Concurrently, Cu5.4O releases substantial amounts of Cu+ into malignant cells, disrupting Cu homeostasis, inducing cuproptosis, and ultimately inhibiting tumor progression. In vivo and in vitro experiments demonstrate that Cu5.4O operates through multiple successive and interlocking stages to significantly eradicate tumors, prevent relapse, and prolong survival. This study provides profound insights into the synergistic effects of PTT, inflammatory regulation, and cuproptosis within the complex tumor microenvironment, presenting innovative approaches for future CRC therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81971680)
- Beijing Science and Technology Planning Project (7242276)
- Bureau of Science and Technology of Ganzhou Municipality (2023LNS26875)
This publication has 45 references indexed in Scilit:
- Acidic biofilm microenvironment-responsive ROS generation via a protein nanoassembly with hypoxia-relieving and GSH-depleting capabilities for efficient elimination of biofilm bacteriaActa Biomaterialia, 2024
- Bioorthogonal Cu Single‐Atom Nanozyme for Synergistic Nanocatalytic Therapy, Photothermal Therapy, Cuproptosis and ImmunotherapyAngewandte Chemie International Edition, 2024
- Cuproptosis in lung cancer: therapeutic options and prognostic modelsApoptosis, 2024
- Carrier‐Free Self‐Assembly Nano‐Sonosensitizers for Sonodynamic‐Amplified Cuproptosis‐Ferroptosis in Glioblastoma TherapyAdvanced Science, 2024
- A Self‐Amplifying ROS‐Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer ImmunotherapyAdvanced Science, 2024
- Efficacy, Safety, and Analysis Issues in a Study of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon CancerJAMA Surgery, 2023
- An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinomaApoptosis, 2023
- Cu Single Atom Nanozyme Based High‐Efficiency Mild Photothermal Therapy through Cellular Metabolic RegulationAngewandte Chemie International Edition, 2022
- PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinomaCancer Immunology, Immunotherapy, 2022
- Recent Advances in Cell Membrane–Camouflaged Nanoparticles for Cancer PhototherapySmall, 2018